Rchr
J-GLOBAL ID:202001012460069798   Update date: Oct. 20, 2021

Sakai Takayuki

サカイ タカユキ | Sakai Takayuki
Affiliation and department:
Job title: 流動研究員
Research field  (3): Pharmaceuticals - chemistry and drug development ,  Cognitive neuroscience ,  Radiology
Papers (4):
  • Takayuki Sakai, Yoshiyuki Matsuo, Kensuke Okuda, Kiichi Hirota, Mieko Tsuji, Tasuku Hirayama, Hideko Nagasawa. Development of antitumor biguanides targeting energy metabolism and stress responses in the tumor microenvironment. Scientific reports. 2021. 11. 1. 4852-4852
  • Kentaro Oh-Hashi, Shiori Matsumoto, Takayuki Sakai, Yoko Hirata, Kensuke Okuda, Hideko Nagasawa. Effects of 2-(2-Chlorophenyl)ethylbiguanide on ERAD Component Expression in HT-29 Cells Under a Serum- and Glucose-Deprived Condition. Applied biochemistry and biotechnology. 2019. 188. 4. 1009-1021
  • Kentaro Oh-Hashi, Shiori Matsumoto, Takayuki Sakai, Yuki Nomura, Kensuke Okuda, Hideko Nagasawa, Yoko Hirata. Elucidating the rapid action of 2-(2-chlorophenyl)ethylbiguanide on HT-29 cells under a serum- and glucose-deprived condition. Cell biology and toxicology. 2018. 34. 4. 279-290
  • Kentaro Oh-Hashi, Nao Irie, Takayuki Sakai, Kensuke Okuda, Hideko Nagasawa, Yoko Hirata, Kazutoshi Kiuchi. Elucidation of a novel phenformin derivative on glucose-deprived stress responses in HT-29 cells. Molecular and cellular biochemistry. 2016. 419. 1-2. 29-40
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page